Download Full Text (593 KB)
• Many patients with asthma have poorly controlled disease despite the use of both an inhaled corticosteroid (ICS) and a long acting beta agonist (LABA).
• The review explored several studies that compared the addition of tiotropium to patients with uncontrolled asthma currently using both a ICA and a LABA to determine if further symptom reduction is obtained along with reduction of exacerbations
• It was found that patients with poorly controlled asthma will benefit from the addition of tiotropium to the current medication regimen of an ICS and a LABA. Tiotropium offers providers an additional disease controlling option in cases where treatment is already limited.
Physician Assistant Studies
Master of Physician Assistant Studies (MPAS)
Anti-Asthmatic Agents -- therapeutic use; Asthma -- drug therapy; Bronchodilator Agents -- therapeutic use; Cholinergic Antagonists -- therapeutic use; Tiotropium Bromide -- therapeutic use
Respiratory Tract Diseases
Gray, Kathryn, "The Addition of Tiotropium in Uncontrolled Asthma" (2014). Physician Assistant Scholarly Project Posters. 118.